Clinical Trial Update: Evaluating the Safety and Antiviral Activity of Monoclonal Antibody VRC01 in Infants With HIV Receiving Combination Antiretroviral Therapy [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial assessed the safety and antiviral activity of the monoclonal antibody VRC01 in infants with HIV on combination antiretroviral therapy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• VRC01 (VRC01)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-05-24